The store will not work correctly when cookies are disabled.
6-chloro-3-{[1-(trifluoromethyl)cyclopropyl]-amino}-4H-thieno[3,2-e]-1,2,4-thiadiazine1,1-dioxide
ID: ALA212479
PubChem CID: 135422331
Max Phase: Preclinical
Molecular Formula: C9H7ClF3N3O2S2
Molecular Weight: 345.75
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S1(=O)N=C(NC2(C(F)(F)F)CC2)Nc2cc(Cl)sc21
Standard InChI: InChI=1S/C9H7ClF3N3O2S2/c10-5-3-4-6(19-5)20(17,18)16-7(14-4)15-8(1-2-8)9(11,12)13/h3H,1-2H2,(H2,14,15,16)
Standard InChI Key: PWZNBODXISXXAG-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
1.8766 -7.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7016 -7.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2891 -7.0441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1461 -8.2749 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.8588 -7.8685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8588 -7.0436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1461 -6.6248 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3511 -8.1210 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.5665 -7.8685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5665 -7.0435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3519 -6.7911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8322 -7.4569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7270 -8.8595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4463 -8.8595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5750 -6.6310 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6573 -7.4590 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.0040 -6.6323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5833 -7.2125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.4125 -6.0417 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.7262 -6.2336 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6 7 1 0
4 13 2 0
9 10 2 0
4 14 2 0
6 15 1 0
10 7 1 0
12 16 1 0
9 4 1 0
4 5 1 0
5 6 2 0
8 9 1 0
10 11 1 0
11 12 2 0
12 8 1 0
15 3 1 0
3 17 1 0
2 1 1 0
17 18 1 0
3 2 1 0
17 19 1 0
1 3 1 0
17 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 345.75 | Molecular Weight (Monoisotopic): 344.9620 | AlogP: 2.56 | #Rotatable Bonds: 1 |
Polar Surface Area: 70.56 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.18 | CX Basic pKa: 0.07 | CX LogP: 2.46 | CX LogD: 2.46 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.82 | Np Likeness Score: -1.04 |
References
1. Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.. (2006) New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells., 49 (14): [PMID:16821773] [10.1021/jm060042j] |